Authors:
KUCZYK MA
BOKEMEYER C
FICHNA B
TRUSS M
SCHMOLL HJ
JONAS U
Citation: Ma. Kuczyk et al., ADULT TERATOMA AS LATE RECURRENCE OF META STASIZED NONSEMINOMATOUS GERM-CELL TUMOR - CASE-REPORT AND CLINICAL IMPLICATIONS, Der Urologe, 34(6), 1995, pp. 480-484
Citation: W. Rhomberg et al., HIGH-FREQUENCY OF METALWORKERS AMONG PATIENTS WITH SEMINOMATOUS TUMORS OF THE TESTIS - A CASE-CONTROL STUDY, American journal of industrial medicine, 28(1), 1995, pp. 79-87
Authors:
FELS LM
GAEDEKE J
STOCKMANN S
BOKEMEYER C
DUNN T
SCHMOLL HJ
STOLTE H
Citation: Lm. Fels et al., PROTECTION OF CYTOSTATIC INDUCED NEPHROTOXICITY BY SILIBININ AND SUPEROXIDE-DISMUTASE (SOD), Kidney international, 47(3), 1995, pp. 971-971
Authors:
LINK H
ARSENIEV L
BOKEMEYER C
MAIBURG C
KADAR JG
BATTMER K
SUDMEYER L
SCHMOLL HJ
GANSER A
Citation: H. Link et al., LIMITED LOW NUMBERS OF AUTOLOGOUS CD34(-CELLS FOR HEMATOPOIETIC RESCUE AFTER MULTIPLE CONSECUTIVE COURSES OF INTENSIFIED CHEMOTHERAPY() BLOOD), Blood, 86(10), 1995, pp. 465-465
Citation: Hg. Derigs et al., STAGE-ORIENTED TREATMENT OF NONSEMINOMATO US TESTICULAR-TUMOR, Deutsche Medizinische Wochenschrift, 119(5), 1994, pp. 156-164
Authors:
SCHEDLOWSKI M
JUNG C
SCHIMANSKI G
TEWES U
SCHMOLL HJ
Citation: M. Schedlowski et al., EFFECTS OF BEHAVIORAL INTERVENTION ON PLASMA-CORTISOL AND LYMPHOCYTESIN BREAST-CANCER PATIENTS - AN EXPLORATORY-STUDY, Psycho-oncology, 3(3), 1994, pp. 181-187
Authors:
CASPER J
CASPER S
KOHNEWOMPNER CH
BOKEMEYER C
HECKER H
SCHMOLL HJ
Citation: J. Casper et al., 5-HT3 ANTAGONIST ONDANSETRON FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN AN OUTPATIENT POPULATION, International journal of oncology, 4(6), 1994, pp. 1283-1289
Authors:
STAHL M
WILKE H
MEYER HJ
PREUSSER P
BERNS T
FINK U
ACHTERRATH W
KNIPP H
HARSTRICK A
BERGER M
SCHMOLL HJ
Citation: M. Stahl et al., 5-FLUOROURACIL, FOLINIC ACID, ETOPOSIDE AND CISPLATIN CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC CARCINOMA OF THE ESOPHAGUS, European journal of cancer, 30A(3), 1994, pp. 325-328
Authors:
HILL BT
SHELLARD SA
FICHTINGERSCHEPMAN AMJ
SCHMOLL HJ
HARSTRICK A
Citation: Bt. Hill et al., DIFFERENTIAL FORMATION AND ENHANCED REMOVAL OF SPECIFIC CISPLATIN-DNAADDUCTS IN 2 CISPLATIN-SELECTED RESISTANT HUMAN TESTICULAR TERATOMA SUBLINES, Anti-cancer drugs, 5(3), 1994, pp. 321-328
Authors:
BOKEMEYER C
SCHMOLL HJ
VANRHEE J
KUCZYK M
SCHUPPERT F
POLIWODA H
Citation: C. Bokemeyer et al., LONG-TERM GONADAL TOXICITY AFTER THERAPY FOR HODGKINS AND NON-HODGKINS-LYMPHOMA, Annals of hematology, 68(3), 1994, pp. 105-110
Citation: Ch. Kohnewompner et al., ADJUVANT THERAPY FOR COLON ADENOCARCINOMA - CURRENT STATUS OF CLINICAL INVESTIGATION, Annals of oncology, 5, 1994, pp. 190000097-190000104
Authors:
SIEGERT W
BEYER J
STROHSCHEER I
BAURMANN H
OETTLE H
ZINGSEM J
ZIMMERMANN R
BOKEMEYER C
SCHMOLL HJ
HUHN D
Citation: W. Siegert et al., HIGH-DOSE TREATMENT WITH CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY GERM-CELL CANCER - A PHASE I II STUDY/, Journal of clinical oncology, 12(6), 1994, pp. 1223-1231
Citation: C. Bokemeyer et al., TREATMENT OF ADULT SOFT-TISSUE SARCOMAS WITH DOSE-INTENSIFIED CHEMOTHERAPY AND HEMATOPOIETIC GROWTH-FACTORS, Onkologie, 17(3), 1994, pp. 216-225
Authors:
BERGER HG
EIGLER FW
ENGELHARDT R
HARTUNG G
HERFARTH C
HERMANEK P
HERRMANN R
HOSSFELD DK
JUNGINGER T
KIRCHNER R
KREUSER E
LAFFER U
LINK KH
MEYER HJ
PICHLMAIER H
QUEISSER W
RAAB HR
SAUER R
SCHEIBE O
SCHMOLL HJ
STOCK W
WILKE H
Citation: Hg. Berger et al., ADJUVANT THERAPY FOR PATIENTS WITH COLON AND RECTAL-CANCER - CONSENSUS OF CAO, AIO AND ARO, Onkologie, 17(3), 1994, pp. 291-293
Authors:
WILKE H
PREUSSER P
STAHL M
MEYER HJ
FINK U
ACHTERRATH W
BUSCHE P
MEYER J
HARSTRICK A
SCHMOLL HJ
SEEBER S
Citation: H. Wilke et al., PHASE-II STUDY WITH FOLINIC ACID, ETOPOSIDE, 5-FLUOROURACIL AND CISPLATIN (FLEP) FOR ADVANCED GASTRIC-CANCER, Onkologie, 17(2), 1994, pp. 154-157
Authors:
BOKEMEYER C
SCHMOLL HJ
NATT F
KNOCHE M
BEYER J
SOUCHON R
Citation: C. Bokemeyer et al., PRELIMINARY-RESULTS OF A PHASE I II TRIAL OF PACLITAXEL IN PATIENTS WITH RELAPSED OR CISPLATIN-REFRACTORY TESTICULAR CANCER/, Journal of cancer research and clinical oncology, 120(12), 1994, pp. 754-757
Authors:
BOKEMEYER C
HARSTRICK A
RUTHER U
METZNER B
ILLIGER HJ
CLEMM C
SIEGERT W
LINK H
OSTERMANN H
SCHMOLL HJ
Citation: C. Bokemeyer et al., ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF GERM-CELL TUMORS, Seminars in oncology, 21(6), 1994, pp. 57-63
Authors:
BOKEMEYER C
DUNN T
HARSTRICK A
LERCH T
POLIWODA H
SCHMOLL HJ
Citation: C. Bokemeyer et al., MODULATION OF CYTOSTATIC DRUGS BY NIFEDIPINE IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR-CANCER CELL-LINES DIFFERING IN THEIR SENSITIVITY TO STANDARD AGENTS, International journal of cancer, 56(3), 1994, pp. 452-456